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up to 64 cells, Sox-9 was identified in all cells, along with c-Myc,
nucleostemin and the proteolytic enzymes. RT-PCR confirmed
expression of nucleostemin, c-myc and Sox-9.
Conclusions: Early expression of c-myc may indicate tempo-
rary genomic instability, i.e. a gene expression pattern in flux.
Because nucleostemin is found only in stem cells or cancer, the
presence in clonal chondrocytes is surprising and suggests that
chondrocytes undergo a de-differentiation to a progenitor-like in-
termediate. The re-activation of Sox-9 in late clones suggests
reversion to an earlier chondrocytic differentiation stage. Over-
all, the findings suggest that OA chondrocytes, because they
still retain some chondrocytic characteristics, display a com-
plicated and mixed phenotype, with degradative chondrocytes
arising from a progenitor-cell like intermediate stage, followed
by re-differentiation. At the same time, the observations do not
support the concept of continued differentiation to hypertrophic
chondrocytes.
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Purpose: Osteogenic Protein-1 (OP-1) is a potent growth fac-
tor for cartilage repair due to its pro-anabolic and anti-catabolic
activities. Our goal was to evaluate the role of OP-1 in human
cartilage homeostasis by gene array under conditions of lack
(inhibition of endogenous OP-1 gene by antisense oligos) or ex-
cess of OP-1 (stimulation with recombinant OP-1 [rhOP-1]). This
report is limited to the effect on anabolic genes (growth factors,
regulators of their signaling and matrix proteins) and catabolic
genes (inflammatory cytokines, their receptors, proteinases, and
transcription factors).
Methods: Human normal adult articular cartilage was obtained
from the ankle joints of 12 tissue donors, age 55-70 y/o, within
24 hours of death. After enzymatic digestion chondrocytes were
plated at high-density monolayers and either transfected with
OP-1 antisense oligos in the presence of lipofectin or treated
with rhOP-1 for 48 hours followed by RNA isolation. Gene ex-
pression profile was analyzed by HG-U133A gene chips from
Affimetrix. RNA within each treatment group was pooled from
all donors. Statistical analysis consisted of 1) analysis of differ-
entially expressed genes under single experimental condition in
comparison to control (up- or down-regulated in the presence
of OP-1 antisense or rhOP-1); 2) analysis of differentially regu-
lated genes by both treatments (OP-1 antisense and rhOP-1);
and 3) gene ontology. Selected gene array data were verified
experimentally in vitro or by real-time PCR.
Results: The results showed that the inhibition of endogenous
OP-1 led to down-regulation of a number of anabolic genes
among which were the members of the IGF-1 pathway: IGF-1
receptor (1.73-fold decrease), IGFBP-5 (1.9 fold) and IGFBP-7
(1.58-fold, P<0.01). In vitro validation experiments confirmed and
extended these findings: in chondrocytes treated with OP-1 anti-
sense expression of IGF-1 and its receptor was down-regulated,
while stimulation with rhOP-1 up-regulated their expression. This
in turn restored the response to IGF-1 diminished with aging
of human cartilage. Antisense inhibition of OP-1 reduced gene
expression of the TGF-β/BMP receptors and downstream signal-
ing/regulatory molecules. RhOP-1 inhibited BMP-2 (2.67-fold),
GDF-15 (3.04-fold), and activin (2.32-fold) expression. The fol-
lowing matrix proteins were regulated by OP-1: rhOP-1 induced
collagen type IX, COMP, and cadherin genes; while OP-1 an-
tisense reduced collagen type VI, versican, syndecan, bone
sialoprotein, and other genes. Among catabolic genes the most
affected by OP-1 were leukemia inhibitory factor (LIF), IL-6, IL-8,
IL-11, IL-1 and IL-6 receptors, NF-κB and AP-2. Inhibition of
OP-1 caused a 2-fold increase in their expression (p<0.001),
while treatment with rhOP-1 dramatically inhibited these genes:
LIF by 15.86-fold; IL-6 by 2-fold; IL-8 by 4.0-fold; and IL-11 by
8.69-fold (p<0.001). These changes were confirmed by real-time
PCR. In addition, OP-1 was not only able to reduce gene ex-
pression of autocrine cytokines, but counteracted their inhibitory
effect on proteoglycan synthesis. OP-1 also inhibited MMP-14
and TIMP-3, some caspases, ADAMs and ADAM-TSs.
Conclusions: The initial analysis of gene array data strongly
suggests a critical role of OP-1 in cartilage homeostasis. OP-1
regulates numerous metabolic pathways that are not only limited
to its anabolic function, but also to its anti-catabolic activity.
Understanding of OP-1 function in cartilage will provide strong
justification for the application of OP-1 protein as therapeutic
treatment for cartilage regeneration and repair.
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Purpose: Traumatic injury to a joint is known to increase the
risk of developing secondary osteoarthritis (OA). Various in-vitro
models of injurious loading have been employed to simulate the
effects of joint injury on articular cartilage. The aim of this study
was to compare two of the most common types of pathological
loading models; a single, fast impact load and a slow, severe
load.
Methods: Full depth, circular explants (5 mm diameter) of artic-
ular cartilage were removed from the subchondral bone of two
human femoral heads using a cork borer and scalpel and cul-
tured for 24 h to equilibrate. Explants (n = 24 from each femoral
head), were matched for initial thickness into 3 groups. One
group was subjected to a single, fast impact load using a 500 g
mass dropped from a height of 25 mm in a drop tower. The mean
maximum strain was found and the second group subjected to
loading to the same strain in an Instron materials testing machine
at the fastest available cross-head speed of 40 mm s-1. The third
group served as a control. The modulus was determined from
the maximum gradient of the stress/strain curve for each load.
All explants were then cultured for either 24 h or 72 h. Chondro-
cyte viability was determined in transverse sections (∼500 μm)
using the fluorescein diacetate/propidium iodide method. Frozen
cartilage sections (8 μm) were used to evaluate apoptotic cell
death (TUNEL), matrix damage (haematoxylin and eosin stain),
and glycosaminoglycan (GAG) distribution (toluidine blue stain).
Results: The peak stress of the fast, impact load was 21.7 ±
0.4 MPa and was reached after 1.5 ± 0.1 ms giving a peak
modulus for cartilage of 87.8 ± 13.0 MPa. In comparison, for
slow, severe loading, the peak stress was 0.8 ± 0.2 MPa, with a
duration of 42.4 ± 1.6 ms and a peak modulus of 4.5 ± 1.4 MPa.
Macroscopically, the explants subjected to slow, severe loading
were considerably more damaged than those that were fast im-
pacted; becoming flattened and elliptical in shape with extensive
fissuring. The number of dead cells was also greater with this
type of loading and, after 72 h, only a few viable cells were visible
in the superficial layer. Slow load resulted in about 70% of chon-
drocytes becoming apoptotic by 24 h, and this was unchanged
after 72 h. In contrast, impact loaded explants only had about
10% apoptotic cells (similar to unloaded controls) at 24 h but this
